Technological advancements in the field of breast imaging market and the rising incidence of breast cancer are the major factors driving growth. Additionally, the growing adoption of advanced techniques for breast cancer screening and rising government and private investments for improving breast cancer care are some of the other major factors driving the growth of this market.

The global breast imaging market is projected to reach USD 4.6 billion by 2023 from USD 3.1 billion in 2018, at a CAGR of 8.0%

Don’t miss out on business opportunities in Breast Imaging Market by Technology.

                                                                               Breast Imaging Market

Breast Imaging Market By technology:

the non-ionizing breast imaging segment is expected to grow at the highest rate during the forecast period

Based on technology, the market is segmented into ionizing (mammography, PET-CT, MBI, and PEM) and non-ionizing (breast ultrasound, breast MRI, AWBU, and breast thermography), and other breast imaging technologies (CBCT, electrical impedance tomography, and optical imaging). The ionizing breast imaging technology segment accounted for the largest share of the breast imaging market during the forecast period. The large share of this market segment is primarily due to the technological advancements in ionizing breast imaging technologies and raising awareness about the early screening and diagnosis of breast cancer.

Download PDF( Breast Imaging Market):

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=897

Major Key players operating in the Breast Imaging Market:

Hologic, Inc. (US), GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), FUJIFILM Holdings Corporation (Japan), Aurora Imaging Technology, Inc. (US), Canon Inc. (Japan), CMR Naviscan Corporation (US), Delphinus Medical Technologies, Inc. (US), Dilon Technologies, Inc. (US), KUB Technologies Inc. (Kubtec) (US), Micrima Limited (UK), Planmed Oy (Finland), SonoCiné, Inc. (US), and SuperSonic Imagine (France).

GE Healthcare (US) offers an extensive range of products, including molecular imaging, ultrasound, and magnetic resonance imaging technologies. It has a strong presence and wide industry coverage in North America, South America, Europe, Australia, and Asia. The company has a sound custom services support setup, which helps it to strengthen its customer relationships and presence in the market. During the last three years, the company has significantly invested in R&D activities.

Read More In Detailed (Breast Imaging):

https://www.marketsandmarkets.com/Market-Reports/breast-imaging-technologies-market-897.html